Anonymous ID: ee5c7f May 27, 2020, 5:35 p.m. No.9338277   🗄️.is 🔗kun

Please make this go viral:

 

https://medium.com/@joyce.kamen/weve-cracked-the-covid-19-code-and-why-no-one-is-listening-36f609edc8c2

 

I stopped what I was doing, and told Fred to go to his email and open the message from Glynnis. As we both read through the COVID-19 Critical Care Management Protocol Glynnis sent to us from Dr. Marik — Chief of Pulmonary and Critical Care Medicine at Eastern Virginia Medical School and actually the most published clinical researcher in Critical Care in the country — we both sat with eyes wide and jaws dropped. “People are dying needlessly,” Dr. Marik wrote. “I do not think the White House Coronavirus Task Force is being entirely honest with the American public. Furthermore, the amount of misinformation and the mixed messaging is causing panic and anxiety. While Dr. Fauci is a highly respected scientist, he is not on the front lines and does not take care of critically sick patients.”

 

Dr. Marik outlined the early intervention protocol in his document, which began with a dire warning: “The medical community needs to get off their “high pedestal” and act decisively and right now; there is no time to lose. It is likely that 40–80% of the population across the world will become infected with this virus. It is therefore unrealistic for us to expect this will just go away. Our goal should therefore to reduce the mortality in those who are at greatest risk of dying.

 

“[Some in the medical community] are promoting the idea of performing randomized controlled trials (RCTs). I believe that it is unethical to do such trials now. How can you offer patients a placebo when testing a drug that you believe may have clinical efficacy? Every patient needs to get the best treatment we can offer; we would expect no less for our loved ones.”

 

“It is likely that there will not be a single “magic bullet” to cure COVID-19. Rather, we should be using multiple drugs/interventions that have synergistic and overlapping biological effects, that are safe, cheap and could be made readily available. The impact on middle-income and low-income countries will be enormous; these countries will not be able to afford expensive designer molecules.”

 

Dr. Marik’s protocol included the use of pharmacy grade IV ascorbic acid (Vitamin C), which has anti-inflammatory, anti-oxidant, immune enhancing, and antiviral properties that, Dr. Marik says, are likely to be of benefit in patients with COVID-19. Furthermore, he stressed that ascorbic acid has proven synergistic effects when combined with corticosteroids. Therefore, he is recommending steroids (methylprednisolone) in patients with COVID-19 and with moderate to severe Acute Respiratory Distress Syndrome (ARDS) — which is an atypical form of ARDS in COVID-19 patients.

 

Dr. Marik’s protocol also included thiamine, melatonin, Vitamin D, hydrochloroquine, azithromycin, and other drugs in the recommended cocktails — developed for each stage of disease from mild to acute.